Abstract
Primary and secondary prevention of cardiovascular complications (CVC) has been one of the key areas in modern cardiology over the past decades. The article examined the relationship between the risk of CVC and the lipid metabolism parameters. The article discussed the major clinical trials the results of which constitute the evidence base for statins use to reduce the risk of acute coronary and cerebrovascular events.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
